APA

Grimshaw K. M., Hunter L. K., Yap T. A., Heaton S. P., Walton M. I., Woodhead S. J., Fazal L., Reule M., Davies T. G., Seavers L. C., Lock V., Lyons J. F., Thompson N. T., Workman P. & Garrett M. D. (20100820). AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. : Molecular cancer therapeutics.

Chicago

Grimshaw Kyla M, Hunter Lisa-Jane K, Yap Timothy A, Heaton Simon P, Walton Mike I, Woodhead Steven J, Fazal Lynsey, Reule Matthias, Davies Thomas G, Seavers Lisa C, Lock Victoria, Lyons John F, Thompson Neil T, Workman Paul and Garrett Michelle D. 20100820. AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. : Molecular cancer therapeutics.

Harvard

Grimshaw K. M., Hunter L. K., Yap T. A., Heaton S. P., Walton M. I., Woodhead S. J., Fazal L., Reule M., Davies T. G., Seavers L. C., Lock V., Lyons J. F., Thompson N. T., Workman P. and Garrett M. D. (20100820). AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. : Molecular cancer therapeutics.

MLA

Grimshaw Kyla M, Hunter Lisa-Jane K, Yap Timothy A, Heaton Simon P, Walton Mike I, Woodhead Steven J, Fazal Lynsey, Reule Matthias, Davies Thomas G, Seavers Lisa C, Lock Victoria, Lyons John F, Thompson Neil T, Workman Paul and Garrett Michelle D. AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. : Molecular cancer therapeutics. 20100820.